Abstract
Objective: This study was undertaken to investigate the rates and predictors of follow-up and treatment for postpartum patients with a positive purified protein derivative (PPD). Study design: Retrospective cohort study of all women delivered at San Francisco General Hospital in 2000. All patients with a positive PPD were identified and their demographic and PPD follow-up and treatment data were collected and analyzed. Results: Among the 1331 patients delivered, the prevalence of a positive PPD was 32% (n= 425). Of the 393 patients who had not been previously treated, 42% (n = 167) attended a follow-up visit with 42% of these (n = 71) actually completing 6 months of therapy. Among different ethnicities, Asian patients were more likely to follow-up at a rate of 52% (P = .03). Patients who received care from the same physician both antepartum and postpartum were more likely to attend and complete therapy at rates of 67% (P < .001) and 62% (P = .01), respectively. Conclusion: We found that despite the opportunity given by the interaction with the medical system during pregnancy, only 18% of patients with a positive PPD actually completed therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 1455-1457 |
Number of pages | 3 |
Journal | American journal of obstetrics and gynecology |
Volume | 192 |
Issue number | 5 SPEC. ISS. |
DOIs | |
State | Published - May 2005 |
Externally published | Yes |
Keywords
- Latent tuberculosis infection
- Pregnancy
- Purified protein derivative
- Tuberculosis
ASJC Scopus subject areas
- Obstetrics and Gynecology